Century Therapeutics, Inc. (IPSC)
NASDAQ · Healthcare
Century Therapeutics, Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 109.2M | 6.6M | 2.2M | 5.2M |
| Gross Profit | — | — | — | — |
| Profitability | ||||
| Operating Income | -17.3M | -138.1M | -146.5M | -133.8M |
| EBITDA | — | — | — | — |
| Net Income | -9.6M | -126.6M | -136.7M | -130.9M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 87M | 79M | 59M | 32M |
Century Therapeutics, Inc. Income Statement — FAQ
Century Therapeutics, Inc. (IPSC) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IPSC's income statement history?
The chart and table above show Century Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.